A medical view of potential adverse effects.
Chatterjee
Anjan
A
D000662:Amphetamines / Q000009:adverse effects*; D024803:Biomedical Enhancement / Q000941:ethics*; D000697:Central Nervous System Stimulants / Q000009:adverse effects*; D004348:Drug Labeling; D006801:Humans; D008774:Methylphenidate / Q000009:adverse effects*; D018570:Risk Assessment; D012959:Socioeconomic Factors; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence
C090411:Adderall; D000662:Amphetamines; D000697:Central Nervous System Stimulants; D008774:Methylphenidate